Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice.

Byrnes JJ, Gross S, Ellard C, Connolly K, Donahue S, Picarella D.

Inflamm Res. 2009 Nov;58(11):819-27. doi: 10.1007/s00011-009-0053-3. Epub 2009 Jun 11.

PMID:
19517214
2.

Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.

Naito Y, Katada K, Takagi T, Tsuboi H, Isozaki Y, Handa O, Kokura S, Yoshida N, Ichikawa H, Yoshikawa T.

Int J Mol Med. 2006 Jun;17(6):997-1004.

PMID:
16685407
3.

The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.

Lu F, Fernandes SM, Davis AE 3rd.

Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G878-83. doi: 10.1152/ajpgi.00400.2009. Epub 2010 Mar 25.

4.

The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice.

Hans W, Schölmerich J, Gross V, Falk W.

Eur J Gastroenterol Hepatol. 2000 Mar;12(3):267-73.

PMID:
10750645
5.

Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine.

Axelsson LG, Landström E, Bylund-Fellenius AC.

Aliment Pharmacol Ther. 1998 Sep;12(9):925-34.

6.

Lactobacillus casei secreting alpha-MSH induces the therapeutic effect on DSS-induced acute colitis in Balb/c Mice.

Yoon SW, Lee CH, Kim JY, Kim JY, Sung MH, Poo H.

J Microbiol Biotechnol. 2008 Dec;18(12):1975-83.

7.

Partially hydrolyzed guar gum down-regulates colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.

Naito Y, Takagi T, Katada K, Uchiyama K, Kuroda M, Kokura S, Ichikawa H, Watabe J, Yoshida N, Okanoue T, Yoshikawa T.

J Nutr Biochem. 2006 Jun;17(6):402-9. Epub 2005 Sep 22.

PMID:
16214331
8.

Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.

Kannengiesser K, Maaser C, Heidemann J, Luegering A, Ross M, Brzoska T, Bohm M, Luger TA, Domschke W, Kucharzik T.

Inflamm Bowel Dis. 2008 Mar;14(3):324-31.

PMID:
18092346
9.

R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.

Zhao J, de Vera J, Narushima S, Beck EX, Palencia S, Shinkawa P, Kim KA, Liu Y, Levy MD, Berg DJ, Abo A, Funk WD.

Gastroenterology. 2007 Apr;132(4):1331-43. Epub 2007 Feb 6.

PMID:
17408649
10.

Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.

Karlsson A, Jägervall A, Pettersson M, Andersson AK, Gillberg PG, Melgar S.

Int Immunopharmacol. 2008 Jan;8(1):20-7. Epub 2007 Oct 29.

PMID:
18068096
11.

Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice.

Ohkawara T, Takeda H, Kato K, Miyashita K, Kato M, Iwanaga T, Asaka M.

Scand J Gastroenterol. 2005 Nov;40(11):1321-7.

PMID:
16334442
12.

The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice.

Martín AR, Villegas I, Alarcón de la Lastra C.

Inflamm Res. 2005 Apr;54(4):145-51.

PMID:
15883736
13.

Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity.

You Y, Fu JJ, Meng J, Huang GD, Liu YH.

Dig Dis Sci. 2009 Aug;54(8):1643-50. doi: 10.1007/s10620-008-0563-9. Epub 2008 Nov 26.

PMID:
19034653
14.

A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice.

Villegas I, Alarcón de la Lastra C, Orjales A, La Casa C.

Int Immunopharmacol. 2003 Dec;3(13-14):1731-41.

PMID:
14636824
15.

DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.

Nam SY, Kim JS, Kim JM, Lee JY, Kim N, Jung HC, Song IS.

Exp Biol Med (Maywood). 2008 Feb;233(2):180-91. doi: 10.3181/0707-RM-186.

PMID:
18222973
16.

Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice.

Katada K, Yoshida N, Suzuki T, Okuda T, Mizushima K, Takagi T, Ichikawa H, Naito Y, Cepinskas G, Yoshikawa T.

Inflamm Res. 2008 Feb;57(2):84-91. doi: 10.1007/s00011-007-7098-y.

PMID:
18288458
17.

Adenosine kinase inhibitor GP515 improves experimental colitis in mice.

Siegmund B, Rieder F, Albrich S, Wolf K, Bidlingmaier C, Firestein GS, Boyle D, Lehr HA, Loher F, Hartmann G, Endres S, Eigler A.

J Pharmacol Exp Ther. 2001 Jan;296(1):99-105.

18.

Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.

Bank U, Heimburg A, Helmuth M, Stefin S, Lendeckel U, Reinhold D, Faust J, Fuchs P, Sens B, Neubert K, Täger M, Ansorge S.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1925-34. Epub 2006 Oct 17.

PMID:
17161345
19.

Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.

Khalil PN, Weiler V, Nelson PJ, Khalil MN, Moosmann S, Mutschler WE, Siebeck M, Huss R.

Gastroenterology. 2007 Mar;132(3):944-54. Epub 2006 Dec 19.

PMID:
17383423
20.

Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis.

Miceli R, Hubert M, Santiago G, Yao DL, Coleman TA, Huddleston KA, Connolly K.

J Pharmacol Exp Ther. 1999 Jul;290(1):464-71.

Items per page

Supplemental Content

Write to the Help Desk